DENVER – JULY 18, 2023 — Cleerly, the company on a mission to eliminate heart attacks by creating a new standard of care for heart disease, today announced a partnership with Cenegenics, a leading performance health age management platform dedicated to helping people achieve their peak cognitive, physical and metabolic health. Through […]
Tag: Cleerly
Cleerly Wins 2023 Artificial Intelligence Breakthrough Award
Prestigious International Annual Awards Program Honors Standout AI and Machine Learning Solutions and Companies DENVER–(BUSINESS WIRE)–Cleerly, the company creating a new standard of care for heart disease, today announced that it has been named “Best Overall AI Solution” in the sixth annual AI Breakthrough Awards program conducted by AI Breakthrough, a […]
Cleerly Partners with ProScan Imaging to Transform the Standard of Care for Heart Disease Prevention
ProScan’s imaging centers in two major regions will now leverage Cleerly’s AI-enabled approach to develop personalized heart care diagnoses and treatment plans DENVER – May 31, 2023 — Cleerly, the company creating a new standard of care for heart disease, announced today a partnership with ProScan Imaging to offer more personalized […]
Cleerly Expands Executive Team With Appointment of New Chief Financial Officer and Executive Vice President of Regulatory Affairs Positions
Krissy Wright joins as CFO and Sandra Statz as EVP of Regulatory Affairs to Support Company’s Mission to Create a World Without Heart Attacks May 01, 2023 09:00 AM Eastern Daylight Time NEW YORK–(BUSINESS WIRE)–Cleerly, the company creating a new standard of care for heart disease, announced today it has […]
Cardiac AI-Pioneer Cleerly Partners with ClearDATA to Protect Patient Data
Cleerly revolutionizes precision healthcare by leveraging secure patient imaging for AI interpretation AUSTIN, Texas, Feb. 14, 2023 (GLOBE NEWSWIRE) — ClearDATA®, healthcare’s most comprehensive managed cloud, compliance and cyber defense provider, today announced a partnership with Cleerly, the company leveraging artificial intelligence (AI) to forge a new standard of prevention and care […]
Cleerly Hires Udo Hoffmann, MD, MPH as Chief Scientific Officer
Cardiovascular clinical trial expert brings AI imaging experience to lead research efforts NEW YORK–(BUSINESS WIRE)–Cleerly, the company creating a new standard of care for heart disease, announced it has appointed Udo Hoffmann, MD, MPH, as chief scientific officer. In this role, Dr. Hoffmann will oversee Cleerly’s large-scale research efforts, including […]
Cleerly partners with Heartbeat Health in new heart disease detection program
New alliance combines Cleerly’s AI-enabled approach to identifying early signs of heart disease with Heartbeat Health’s nationwide footprint of virtual cardiologists and care NEW YORK–(BUSINESS WIRE)–Cleerly, the company creating a new standard of care for heart disease, and Heartbeat Health, the nation’s largest virtual-first cardiovascular company, today announced a partnership to […]
Cleerly Introduces Proxy Solution to Improve Heart Disease Imaging Workflows
Proxy allows for seamless data transmission and improved AI-based plaque analysis NEW YORK–(BUSINESS WIRE)–Cleerly, the company creating a new standard of care for heart disease, announced a new workflow solution to its portfolio, Proxy. Cleerly Proxy is a software that allows Cleerly to seamlessly transmit data to care providers by […]
Heart Health Innovator Cleerly Appoints Joseph Jasser, MD, as Chief of Value Based Care
Hire follows Cleerly’s $223 million Series C and furthers value-based care business strategy NEW YORK–(BUSINESS WIRE)–Cleerly, the company creating a new standard of care for heart disease, announced it has appointed Joseph “Joe” Jasser, MD, as chief of value based care. In this role, Dr. Jasser will be responsible for […]
Heart Health Innovator Cleerly Closes Series C Funding Round with $192 Million High-profile investors led by T. Rowe Price and Fidelity back a new standard of care for cardiovascular disease
This press release was updated on July 28, 2022 to reflect that Cleerly secured additional Series C funding, raising its round total from $192 million to $223 million. Updated July 28, 2022: New York – July 25, 2022 — Cleerly, the company creating a new standard of care for heart disease, announced […]



